Filed: 8/14/2024ACC: 0001104659-24-089453
📋 What this filing means
DECHENG CAPITAL LLC filed this quarterly 13F‑HR report disclosing 24 equity positions with a total reported market value of $326.32M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
24
Positions
$326.32M
Total AUM (reported)
29.93M
Total Shares
Allocation by class
COM$307.24M94.2%
SHS$11.90M3.6%
ADR$4.37M1.3%
COM CL A$2.71M0.8%
WARRANTS$103.4K0.0%
Portfolio Concentration
Top 3$205.88M63.1%
4–10$74.93M23.0%
11–25$45.51M13.9%
Top 3 weight
63.1%
Top 10 weight
86.1%
Voting Authority Distribution
Total shares with voting rights: 29.29M
Sole
Full voting authority
29.29M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole24
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings24
Rows:
CG ONCOLOGY INC
SOLEShares5.46M
TypeSH
Market value$172.33M
52.81%
Sole
5.46M
Shared
0.00
None
0.00
Nuvation Bio Inc.
SOLEShares6.95M
TypeSH
Market value$20.29M
6.22%
Sole
6.95M
Shared
0.00
None
0.00
Arcus Biosciences, Inc
SOLEShares869.79K
TypeSH
Market value$13.25M
4.06%
Sole
869.79K
Shared
0.00
None
0.00
Zentalis Pharmaceuticals Inc.
SOLEShares3.07M
TypeSH
Market value$12.56M
3.85%
Sole
3.07M
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares65.77K
TypeSH
Market value$12.08M
3.70%
Sole
65.77K
Shared
0.00
None
0.00
BeyondSpring Inc.
SOLEShares4.96M
TypeSH
Market value$11.90M
3.65%
Sole
4.96M
Shared
0.00
None
0.00
Illumnia, Inc.
SOLEShares108.77K
TypeSH
Market value$11.35M
3.48%
Sole
108.77K
Shared
0.00
None
0.00
MERUS NV
SOLEShares179.10K
TypeSH
Market value$10.60M
3.25%
Sole
179.10K
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares850K
TypeSH
Market value$8.76M
2.68%
Sole
850K
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA CO NV
SOLEShares400K
TypeSH
Market value$7.68M
2.35%
Sole
400K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares166.60K
TypeSH
Market value$7.33M
2.24%
Sole
166.60K
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares347.83K
TypeSH
Market value$7.30M
2.24%
Sole
347.83K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares157.96K
TypeSH
Market value$7.07M
2.17%
Sole
157.96K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares94.04K
TypeSH
Market value$5.10M
1.56%
Sole
94.04K
Shared
0.00
None
0.00
LEGEND BIOTECH CORP-ADR
SOLEShares98.56K
TypeSH
Market value$4.37M
1.34%
Sole
98.56K
Shared
0.00
None
0.00
Aura Biosciences, Inc.
SOLEShares515.55K
TypeSH
Market value$3.90M
1.19%
Sole
515.55K
Shared
0.00
None
0.00
Equillium Inc.
SOLEShares4.45M
TypeSH
Market value$3.08M
0.94%
Sole
4.45M
Shared
0.00
None
0.00
GeneDx Holdings Corp.
SOLEShares103.60K
TypeSH
Market value$2.71M
0.83%
Sole
103.60K
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares69.77K
TypeSH
Market value$2.52M
0.77%
Sole
69.77K
Shared
0.00
None
0.00
Pyxis Oncology, Inc (formerly Apexigen)
SOLEShares326.81K
TypeSH
Market value$1.08M
0.33%
Sole
326.81K
Shared
0.00
None
0.00
AtriCure Inc.
SOLEShares26.80K
TypeSH
Market value$610.2K
0.19%
Sole
26.80K
Shared
0.00
None
0.00
GRAIL INC
SOLEShares18.13K
TypeSH
Market value$278.6K
0.09%
Sole
18.13K
Shared
0.00
None
0.00
Nuvation Bio Inc.
SOLEShares646.06K
TypeSH
Market value$103.4K
0.03%
Sole
0.00
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares1.18K
TypeSH
Market value$65.0K
0.02%
Sole
1.18K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 5.46M | SH | $172.33M 52.81% | 5.46M | 0.00 | 0.00 |
Nuvation Bio Inc.SOLE | COM | 6.95M | SH | $20.29M 6.22% | 6.95M | 0.00 | 0.00 |
Arcus Biosciences, IncSOLE | COM | 869.79K | SH | $13.25M 4.06% | 869.79K | 0.00 | 0.00 |
Zentalis Pharmaceuticals Inc.SOLE | COM | 3.07M | SH | $12.56M 3.85% | 3.07M | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 65.77K | SH | $12.08M 3.70% | 65.77K | 0.00 | 0.00 |
BeyondSpring Inc.SOLE | SHS | 4.96M | SH | $11.90M 3.65% | 4.96M | 0.00 | 0.00 |
Illumnia, Inc.SOLE | COM | 108.77K | SH | $11.35M 3.48% | 108.77K | 0.00 | 0.00 |
MERUS NVSOLE | COM | 179.10K | SH | $10.60M 3.25% | 179.10K | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 850K | SH | $8.76M 2.68% | 850K | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA CO NVSOLE | COM | 400K | SH | $7.68M 2.35% | 400K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | COM | 166.60K | SH | $7.33M 2.24% | 166.60K | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 347.83K | SH | $7.30M 2.24% | 347.83K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 157.96K | SH | $7.07M 2.17% | 157.96K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM | 94.04K | SH | $5.10M 1.56% | 94.04K | 0.00 | 0.00 |
LEGEND BIOTECH CORP-ADRSOLE | ADR | 98.56K | SH | $4.37M 1.34% | 98.56K | 0.00 | 0.00 |
Aura Biosciences, Inc.SOLE | COM | 515.55K | SH | $3.90M 1.19% | 515.55K | 0.00 | 0.00 |
Equillium Inc.SOLE | COM | 4.45M | SH | $3.08M 0.94% | 4.45M | 0.00 | 0.00 |
GeneDx Holdings Corp.SOLE | COM CL A | 103.60K | SH | $2.71M 0.83% | 103.60K | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | COM | 69.77K | SH | $2.52M 0.77% | 69.77K | 0.00 | 0.00 |
Pyxis Oncology, Inc (formerly Apexigen)SOLE | COM | 326.81K | SH | $1.08M 0.33% | 326.81K | 0.00 | 0.00 |
AtriCure Inc.SOLE | COM | 26.80K | SH | $610.2K 0.19% | 26.80K | 0.00 | 0.00 |
GRAIL INCSOLE | COM | 18.13K | SH | $278.6K 0.09% | 18.13K | 0.00 | 0.00 |
Nuvation Bio Inc.SOLE | WARRANTS | 646.06K | SH | $103.4K 0.03% | 0.00 | 0.00 | 0.00 |
ARCELLX INCSOLE | COM | 1.18K | SH | $65.0K 0.02% | 1.18K | 0.00 | 0.00 |